[Treatment of cancer ascites by combined intraperitoneal administration of low-dose CDDP and reinfusion of ultra-filtrated and concentrated ascitic fluid in patients]. 1999

Y Takahashi, and H Imai, and A Ikawa, and K Yasuda, and M Kawai, and T Yamamori, and N Furuichi, and K Misawa, and H Ohashi
Dept. of Surgery, Gifu Prefectural Hospital.

Ascites due to carcinomatous dissemination is a severe problem for end-stage cancer patients. We attempted treating patients on an outpatient basis with the administration of low-dose CDDP-i.p. and reinfusion of ultrafiltrated and concentrated ascites. From 1995, we performed this therapy on 16 patients with concentrated ascites 6-8 fold and reinfusion, combined with low-dose CDDP-i.p. and drip infusion of 5-FU intravenously. The ascitic fluid was significantly decreased after treatment in 8 patients, and 2 patients had lasting low concentrations of CA 125. CA 125 decreased in 83.3% of patients, who tended to have extended survival times after remarkable ascites pooling and treatment with low-dose CDDP-i.p. and reinfusion therapy. This treatment is a useful cant method for decreasing ascites and improving QOL.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Y Takahashi, and H Imai, and A Ikawa, and K Yasuda, and M Kawai, and T Yamamori, and N Furuichi, and K Misawa, and H Ohashi
January 1991, Contributions to nephrology,
Y Takahashi, and H Imai, and A Ikawa, and K Yasuda, and M Kawai, and T Yamamori, and N Furuichi, and K Misawa, and H Ohashi
March 1992, Internal medicine (Tokyo, Japan),
Y Takahashi, and H Imai, and A Ikawa, and K Yasuda, and M Kawai, and T Yamamori, and N Furuichi, and K Misawa, and H Ohashi
May 1993, Digestive diseases and sciences,
Y Takahashi, and H Imai, and A Ikawa, and K Yasuda, and M Kawai, and T Yamamori, and N Furuichi, and K Misawa, and H Ohashi
January 1977, Transactions - American Society for Artificial Internal Organs,
Y Takahashi, and H Imai, and A Ikawa, and K Yasuda, and M Kawai, and T Yamamori, and N Furuichi, and K Misawa, and H Ohashi
January 1979, Zhonghua nei ke za zhi,
Y Takahashi, and H Imai, and A Ikawa, and K Yasuda, and M Kawai, and T Yamamori, and N Furuichi, and K Misawa, and H Ohashi
January 2000, Bratislavske lekarske listy,
Y Takahashi, and H Imai, and A Ikawa, and K Yasuda, and M Kawai, and T Yamamori, and N Furuichi, and K Misawa, and H Ohashi
June 1985, The Journal of pediatrics,
Y Takahashi, and H Imai, and A Ikawa, and K Yasuda, and M Kawai, and T Yamamori, and N Furuichi, and K Misawa, and H Ohashi
December 1977, Canadian Medical Association journal,
Y Takahashi, and H Imai, and A Ikawa, and K Yasuda, and M Kawai, and T Yamamori, and N Furuichi, and K Misawa, and H Ohashi
March 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Y Takahashi, and H Imai, and A Ikawa, and K Yasuda, and M Kawai, and T Yamamori, and N Furuichi, and K Misawa, and H Ohashi
July 1994, JPMA. The Journal of the Pakistan Medical Association,
Copied contents to your clipboard!